Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3933817 | 0.97 | PDE2A (0.50) | PDE2AALDH1A1MAPTMAPK1NPC1 | |
| SCHEMBL1706121 | 0.87 | PDE2A (0.62) | PDE2AALDH1A1MAPTMAPK1NPC1 | |
| SCHEMBL18266009 | 0.86 | ALDH1A1 (0.52) | PDE2AALDH1A1MAPTMAPK1NPC1 | |
| SCHEMBL13784437 | 0.82 | ALDH1A1 (0.50) | PDE2AALDH1A1MAPTMAPK1NPC1 | |
| SCHEMBL23394996 | 0.81 | KIF11 (0.50) | PDE2AALDH1A1KIF11MEN1KMT2A | |
| SCHEMBL678140 | 0.80 | ALDH1A1 (0.48) | ALDH1A1MAPTMAPK1NPC1RAB9A | |
| SCHEMBL33319 | 0.79 | RAB9A (0.73) | ALDH1A1MAPTMAPK1NPC1RAB9A | |
| SCHEMBL676983 | 0.79 | KIF11 (0.52) | ALDH1A1MAPTMAPK1NPC1RAB9A | |
| SCHEMBL10799109 | 0.79 | ALDH1A1 (0.52) | PDE2AALDH1A1MAPTMAPK1NPC1 | |
| SCHEMBL2202087 | 0.79 | ALDH1A1 (0.52) | ALDH1A1MAPTMAPK1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118043022-A | Composition comprising a dye and an inorganic alkalizing agent | 花王株式会社 | 2024-05-14 | — | — | CN | claimed |
| WO-2025054339-A1 | TRIAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF KIT | ARCUS BIOSCIENCES, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| EP-4486462-A1 | DYEING COMPOSITION IN AQUEOUS-ALCOHOLIC MEDIUM | Kao Corporation (JP) | 2025-01-08 | — | — | EP | disclosed |
| CN-118804737-A | Dyeing composition in aqueous alcohol medium | 花王株式会社 | 2024-10-18 | — | — | CN | disclosed |
| CN-118043022-A | Composition comprising a dye and an inorganic alkalizing agent | 花王株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-20230372297-A1 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | BOEHRINGER INGELHEIM INT (DE) | 2023-11-23 | — | — | US | disclosed |
| WO-2023161423-A1 | DYEING COMPOSITION IN AQUEOUS-ALCOHOLIC MEDIUM | KAO CORPORATION (JP) | 2023-08-31 | — | — | WO | disclosed |
| CN-112209878-B | Cannabinoid receptor light-operated ligand and preparation method and application thereof | 上海科技大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-114615967-A | Two-component oxidation dyeing composition | 花王株式会社 | 2022-06-10 | — | — | CN | disclosed |
| CN-113686796-A | Water quality measuring device and method using multispectral sensor | 淮北师范大学 | 2021-11-23 | — | — | CN | disclosed |
| CN-1303374-A | Substituted indolinones, process for their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA (DE) | 2001-07-11 | — | — | CN | disclosed |
| EP-1100779-A1 | SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim Pharma KG (DE) | 2001-05-23 | — | — | EP | disclosed |
| WO-2001027081-A1 | 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-04-19 | — | — | WO | disclosed |
| WO-2001027080-A2 | 5-SUBSTITUTED INDOLINONES AND USE THEREOF AS KINASE AND CYCLIN/CDK COMPLEX INHIBITORS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-04-19 | — | — | WO | disclosed |
| WO-2001016130-A1 | SUBSTITUTED INDOLINONES AS TYROSINE KINASE INHIBITORS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-03-08 | — | — | WO | disclosed |
| US-6169106-B1 | ANTITUMOUR AGENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-01-02 | — | — | US | disclosed |
| WO-1999062882-A1 | SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-12-09 | — | — | WO | disclosed |
| US-4517357-A | COLORING PAPER | BAYER AKTIENGESELLSCHAFT (DE) | 1985-05-14 | — | — | US | disclosed |
| US-4486348-A | YELLOW COLOR ON PAPER | BAYER AKTIENGESELLSCHAFT (DE) | 1984-12-04 | — | — | US | disclosed |
| US-4276295-A | VASODILATORS, HYPOTENSIVE, ANTIATHEROSCLEROTIC | Ishikawa, Masayuki (JP) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372297-A1 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | MMP1, COL1A1, SMAD3 | PDE2A 987/4885ALDH1A1 174/4885MAPT 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.